205 related articles for article (PubMed ID: 23028604)
1. Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.
Mi Y; Zhang L; Feng N; Wu S; You X; Shao H; Dai F; Peng T; Qin F; Zou J; Zhu L
PLoS One; 2012; 7(9):e44756. PubMed ID: 23028604
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.
Zhu S; Zhang H; Tang Y; Wang J
Urol Int; 2012; 89(2):233-40. PubMed ID: 22890093
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
5. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
6. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
[TBL] [Abstract][Full Text] [Related]
7. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
[TBL] [Abstract][Full Text] [Related]
8. The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects.
Zhang J; Qiu LX; Leaw SJ; Hu XC; Chang JH
Med Oncol; 2011 Sep; 28(3):655-60. PubMed ID: 20354818
[TBL] [Abstract][Full Text] [Related]
9. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects.
Hu YY; Yuan H; Jiang GB; Chen N; Wen L; Leng WD; Zeng XT; Niu YM
PLoS One; 2012; 7(4):e35220. PubMed ID: 22536360
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC
Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448
[TBL] [Abstract][Full Text] [Related]
12. XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.
Li C; Jiang Z; Liu X
Mol Biol Rep; 2010 Jan; 37(1):301-9. PubMed ID: 19669592
[TBL] [Abstract][Full Text] [Related]
13. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M; Ramirez JL; de Aguirre I; Garrido P; Pérez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
[TBL] [Abstract][Full Text] [Related]
16. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
[TBL] [Abstract][Full Text] [Related]
17. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.
Das S; Bhowmik A; Bhattacharjee A; Choudhury B; Naiding M; Laskar AK; Ghosh SK; Choudhury Y
Tumour Biol; 2015 Sep; 36(10):7569-79. PubMed ID: 25916209
[TBL] [Abstract][Full Text] [Related]
18. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of DNA repair genes OGG1 and XPD and the risk of age-related cataract in Egyptians.
Gharib AF; Dabour SA; Etewa RL; Fouad RA
Mol Vis; 2014; 20():661-9. PubMed ID: 24868140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]